文献速递其他结缔组织病

评估系统性硬化症患者中自主神经功能障碍、胃肠传输与临床表型之间的关联

Evaluating the Associations Among Dysautonomia, Gastrointestinal Transit, and Clinical Phenotype in Patients With Systemic Sclerosis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2024-09-10

前瞻性队列纳入91例伴胃肠受累的系统性硬化症患者,用COMPASS-31问卷识别自主神经症状负荷,用全胃肠闪烁显像测胃肠传输。33%患者有全局性自主神经功能障碍(GAD),其更常见于局限型硬皮病和干燥症状,胃和结肠传输更快。上消化道受累与更高的COMPASS-31总分相关。

要点

  • 伴胃肠受累的系统性硬化症患者中33%存在全局性自主神经功能障碍(GAD)。
  • GAD患者更常见局限型硬皮病(93% vs 65%)和干燥症状(100% vs 77%)。
  • GAD患者胃和结肠传输更快(P < 0.05)。

核心结论

  • 伴胃肠受累的系统性硬化症患者中多达三分之一存在全局性自主神经功能障碍症状。
  • 识别与GAD相关的特定临床特征有助于识别可能从调节自主神经系统的治疗中获益的人群。

研究设计与样本

  • 前瞻性队列研究,纳入91例伴胃肠疾病的系统性硬化症患者,在常规就诊时系统采集临床数据。
  • 采用COMPASS-31问卷识别自主神经功能障碍,采用全胃肠闪烁显像测量胃肠传输。
  • 评估COMPASS-31总分与临床特征、胃肠症状及传输的关联,并比较GAD(≥5个COMPASS-31子域阳性)与LAD(<5个阳性子域)患者。

主要发现

  • 患者平均年龄57岁,90%为女性,74%为局限型皮肤病变,83%有显著胃肠疾病(Medsger评分≥2)。
  • 系统性硬化症患者平均COMPASS-31评分为38.8,对照组为7.2;33%为GAD,67%为LAD。
  • GAD患者更常见局限型系统性硬化症(93% vs 65%;P < 0.01)和干燥症状(100% vs 77%;P = 0.01)。
  • GAD患者胃和结肠传输更快(P < 0.05)。
  • 上消化道受累(Medsger胃肠评分1或2)与更高的COMPASS-31总分相关(P = 0.02)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our objective was to identify patients with systemic sclerosis (SSc) with a high burden of autonomic symptoms and to determine whether they have a distinct clinical phenotype, gastrointestinal (GI) transit, or extraintestinal features. METHODS: In a prospective cohort of patients with SSc with GI disease, clinical data were systematically obtained at routine visits. Dysautonomia was identified by the Composite Autonomic Symptom Score (COMPASS)-31questionnaire. GI transit was measured by whole-gut scintigraphy. Associations between total COMPASS-31 scores and clinical features, GI symptoms, and transit were evaluated. Comparisons between patients with global autonomic dysfunction (GAD; ≥5 positive COMPASS-31 subdomains) and those with limited autonomic dysfunction (LAD; <5 positive subdomains) were also studied. RESULTS: A total of 91 patients with SSc and GI involvement were included (mean age 57 years, 90% female, 74% limited cutaneous disease, 83% significant GI disease [Medsger score ≥2]). The mean COMPASS-31 score in patients with SSc was higher than controls (38.8 vs 7.2); 33% had GAD, and 67% had LAD. Patients with GAD were more likely to have limited SSc (93% vs 65%; P < 0.01) and have sicca symptoms (100% vs 77%; P = 0.01). Gastric and colonic transit were faster in patients with GAD (P < 0.05). Upper GI involvement (Medsger GI score of 1 or 2) was associated with higher total COMPASS-31 scores (P = 0.02). CONCLUSION: Symptoms of global dysautonomia are seen in up to one-third of patients with SSc and GI involvement. Identifying specific clinical characteristics associated with GAD in SSc will help to identify a population that may benefit from therapies that modulate the autonomic nervous system.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Alvarez-Hernandez MP, Adler B, Perin J, et al. Evaluating the Associations Among Dysautonomia, Gastrointestinal Transit, and Clinical Phenotype in Patients With Systemic Sclerosis. Arthritis Care Res (Hoboken). 2024. PMID: 39138019. doi:10.1002/acr.25411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。